Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
PRAX on Nasdaq
Shares outstanding
25,726,377
Price per share
$294.04
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
29,465,548
Total reported value
$8,684,885,520
% of total 13F portfolios
0.02%
Share change
+4,717,444
Value change
+$1,519,233,410
Number of holders
244
Price from insider filings
$294.04
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 12% -0.83% $146,484,527 +$12,214,062 2,763,859 +9.1% JANUS HENDERSON GROUP PLC 30 Sep 2025
PERCEPTIVE ADVISORS LLC 7.2% +7.3% $575,742,162 +$182,728,171 1,995,986 +46% Perceptive Advisors LLC 31 Dec 2025
Point72 Asset Management, L.P. 6.1% -35% $452,667,181 -$145,274,958 1,569,309 -24% Steven A. Cohen 31 Dec 2025
FMR LLC 5.4% $398,864,288 1,353,275 FMR LLC 31 Dec 2025
ORBIS INVESTMENT MANAGEMENT LTD 5% $361,304,682 1,252,573 ORBIS INVESTMENT MANAGEMENT LTD 31 Dec 2025
Venrock Healthcare Capital Partners III, L.P. 4.9% -20% $37,813,688 -$6,466,960 1,016,497 -15% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
PRICE T ROWE ASSOCIATES INC /MD/ 4.8% $53,187,885 1,003,545 T. Rowe Price Associates, Inc. 30 Sep 2025
Cormorant Asset Management, LP 4% -46% $53,000,000 -$33,125,000 1,000,000 -38% Cormorant Asset Management, LP 30 Sep 2025
Soleus Capital Master Fund, L.P. 4.6% -8% $40,651,514 -$2,144,555 966,740 -5% Soleus Capital Master Fund, L.P. 30 Jun 2025
Adage Capital Management, L.P. 3.8% -29% $278,444,535 -$98,033,194 965,313 -26% Adage Capital Management, L.P. 31 Dec 2025
Capital Research Global Investors 4.2% $31,759,351 853,746 Capital Research Global Investors 31 Mar 2025
MORGAN STANLEY 2.9% -55% $32,752,940 -$28,575,480 617,980 -47% Morgan Stanley 30 Sep 2025

As of 31 Dec 2025, 244 institutional investors reported holding 29,465,548 shares of Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX). This represents 115% of the company’s total 25,726,377 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX) together control 93% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JANUS HENDERSON GROUP PLC 13% 3,240,086 +17% 0.43% $954,833,974
BlackRock, Inc. 8.1% 2,078,500 +15% 0.01% $612,617,092
PERCEPTIVE ADVISORS LLC 7.8% 1,995,986 +28% 11% $588,296,914
VANGUARD GROUP INC 5.7% 1,460,933 +15% 0.01% $430,595,392
FMR LLC 5.3% 1,358,675 +3044% 0.02% $400,455,884
Orbis Allan Gray Ltd 4.9% 1,255,162 1.6% $369,946,448
BAKER BROS. ADVISORS LP 4.4% 1,126,488 +63% 1.9% $332,021,073
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.8% 965,313 -59% 0.43% $284,516,354
Cormorant Asset Management, LP 3.7% 950,000 -5% 16% $280,003,000
Driehaus Capital Management LLC 3.6% 933,061 +86% 1.9% $275,010,399
DEERFIELD MANAGEMENT COMPANY, L.P. 3.5% 903,351 +7.4% 3.4% $266,253,674
MORGAN STANLEY 3.5% 889,889 +38% 0.02% $262,286,289
STATE STREET CORP 3.4% 882,215 -2.7% 0.01% $260,024,049
PRICE T ROWE ASSOCIATES INC /MD/ 3.1% 785,987 -22% 0.02% $231,662,000
GOLDMAN SACHS GROUP INC 2.8% 716,184 +21% 0.03% $211,088,072
GEODE CAPITAL MANAGEMENT, LLC 2.2% 562,379 +23% 0.01% $165,783,193
BARCLAYS PLC 2.1% 530,751 +593% 0.06% $156,433,549
BANK OF AMERICA CORP /DE/ 2% 522,763 +8.3% 0.01% $154,079,168
Point72 Asset Management, L.P. 1.9% 492,346 -67% 0.23% $145,114,060
Assenagon Asset Management S.A. 1.6% 408,787 -0.24% 0.18% $120,485,880
Logos Global Management LP 1.5% 375,000 +200% 7.4% $110,527,500
RA CAPITAL MANAGEMENT, L.P. 1.5% 373,787 1.1% $110,169,980
Soleus Capital Management, L.P. 1.4% 362,966 -58% 4.5% $106,980,599
FRANKLIN RESOURCES INC 1.4% 356,074 +13% 0.03% $104,949,253
Vivo Capital, LLC 1.3% 328,895 +65% 6.3% $96,938,512

Institutional Holders of Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 29,465,548 $8,684,885,520 +$1,519,233,410 $294.74 244
2025 Q3 24,666,145 $1,307,300,657 +$38,898,898 $53.00 150
2025 Q2 24,151,627 $1,015,573,040 +$43,479,424 $42.05 141
2025 Q1 23,362,159 $886,031,367 +$1,335,704 $37.87 147
2024 Q4 21,720,756 $1,671,718,000 +$223,523,316 $76.96 160
2024 Q3 18,868,572 $1,091,231,093 +$44,014,289 $57.54 132
2024 Q2 18,424,832 $762,133,327 +$67,529,667 $41.36 113
2024 Q1 15,918,361 $971,295,549 +$514,747,070 $61.02 110
2023 Q4 7,555,380 $168,332,336 +$168,332,336 $22.28 57